Nosso grupo organiza mais de 3.000 Séries de conferências Eventos todos os anos nos EUA, Europa e outros países. Ásia com o apoio de mais 1.000 Sociedades e publica mais de 700 Acesso aberto Periódicos que contém mais de 50.000 personalidades eminentes, cientistas de renome como membros do conselho editorial.

Periódicos de acesso aberto ganhando mais leitores e citações
700 periódicos e 15 milhões de leitores Cada periódico está obtendo mais de 25.000 leitores

Abstrato

Voriconazole Eye Drops: A Revolutionary Approach for Treating Fungal Keratitis

Naomi Morgan

Fungal keratitis is a severe and potentially sight-threatening infection of the cornea caused by various species of fungi. It poses a significant challenge to ophthalmologists due to its aggressive nature and resistance to conventional treatments. In recent years, Voriconazole eye drops have emerged as a promising therapy for fungal keratitis, offering improved efficacy and better patient outcomes. This article explores the use of Voriconazole eye drops as a treatment option for fungal keratitis, highlighting its mechanism of action, effectiveness, and safety profile. Voriconazole is a novel antifungal agent with excellent broad spectrum activity commercially available for oral and intravenous administration. The purpose of this study was to prepare ophthalmic formulation of hydroxypropyl beta cyclodextrin based voriconazole containing benzalkonium chloride BAK and EDTA with or without viscosity modifiers and study its permeation characteristics through freshly excised goat cornea.